Glyceollins, a group of novel phytoalexins consisting of three isomers (I, II and III), were isolated from activated soy, and demonstrated to be novel antiestrogens that bind to the ER and inhibit estrogen-induced tumor progression [21]. Here, ESR1 is linked to neoplasm.